These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Human muscle pyruvate dehydrogenase activity. Evans OB Neurology; 1983 Jan; 33(1):51-6. PubMed ID: 6687364 [TBL] [Abstract][Full Text] [Related]
49. Active pyruvate dehydrogenase in platelets from Friedreich's ataxia patients. Filla A; Butterworth RF; Barbeau A Can J Neurol Sci; 1980 Nov; 7(4):417-9. PubMed ID: 7214256 [TBL] [Abstract][Full Text] [Related]
50. Can rehabilitation improve the health and well-being in Friedreich's ataxia: a randomized controlled trial? Milne SC; Corben LA; Roberts M; Murphy A; Tai G; Georgiou-Karistianis N; Yiu EM; Delatycki MB Clin Rehabil; 2018 May; 32(5):630-643. PubMed ID: 29072092 [TBL] [Abstract][Full Text] [Related]
52. Friedreich's ataxia: a histochemical and biochemical study. I. Enzymes of carbohydrate metabolism. Robinson N Acta Neuropathol; 1966 Jan; 6(1):25-34. PubMed ID: 5968191 [No Abstract] [Full Text] [Related]
53. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB; Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651 [TBL] [Abstract][Full Text] [Related]
54. Dicarboxylic amino acid uptake in normal, Friedreich's ataxia, and dicarboxylic aminoaciduria fibroblasts. Melancon SB; Grenier B; Dallaire L; Potier M; Fontaine G; Grignon B; Geoffroy G; Lemieux B; Barbeau A Can J Neurol Sci; 1979 May; 6(2):263-73. PubMed ID: 487320 [TBL] [Abstract][Full Text] [Related]
55. Friedreich's ataxia. Revision of the phenotype according to molecular genetics. Schöls L; Amoiridis G; Przuntek H; Frank G; Epplen JT; Epplen C Brain; 1997 Dec; 120 ( Pt 12)():2131-40. PubMed ID: 9448568 [TBL] [Abstract][Full Text] [Related]
56. Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study. Trouillas P; Serratrice G; Laplane D; Rascol A; Augustin P; Barroche G; Clanet M; Degos CF; Desnuelle C; Dumas R Arch Neurol; 1995 May; 52(5):456-60. PubMed ID: 7733839 [TBL] [Abstract][Full Text] [Related]
57. Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report. Gallagher CL; Waclawik AJ; Beinlich BR; Harding CO; Pauli RM; Poirer J; Pandolfo M; Salamat MS J Child Neurol; 2002 Jun; 17(6):453-6. PubMed ID: 12174969 [TBL] [Abstract][Full Text] [Related]
58. Rationale for clinical trials of selenium as an antioxidant for the treatment of the cardiomyopathy of Friedreich's ataxia. Fryer MJ Med Hypotheses; 2002 Feb; 58(2):127-32. PubMed ID: 11812188 [TBL] [Abstract][Full Text] [Related]
59. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998 [TBL] [Abstract][Full Text] [Related]
60. Taurine in cerebrospinal fluid in Friedreich's ataxia. Lemieux B; Giguere R; Barbeau A; Melancon S; Shapcott D Can J Neurol Sci; 1978 Feb; 5(1):125-9. PubMed ID: 647488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]